SPRYD7 and colorectal carcinoma: SPRYD7 upregulation was confirmed at the mRNA and protein level in the four CRC cell lines, highlighting a pronounced increase in SPRYD7 in the KM12C poorly metastatic and SW480 non-metastatic cells.